The activated partial thromboplastin time in early diagnosis of myocardial infarction

Blood Coagulation and Fibrinolysis

Volumn 12, Issue 6, 2001, Pages 495-499

  Madi, A M ^a   Greci, L S ^a   Nawaz, H ^a   Katz, David L ^a,b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Yale Griffin Prevention Research Center   (United States)

Author keywords

Activated partial thromboplastin time; Acute myocardial infarction; Diagnosis; Hypercoagulable state; Thrombosis

Indexed keywords

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; HEART INFARCTION; HUMAN; HYPERCOAGULABILITY; MAJOR CLINICAL STUDY; MALE; PARTIAL THROMBOPLASTIN TIME; PATHOGENESIS; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; THORAX PAIN; THROMBOSIS;

AGED; BIOLOGICAL MARKERS; CHEST PAIN; COHORT STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PARTIAL THROMBOPLASTIN TIME; REFERENCE VALUES; RETROSPECTIVE STUDIES; RISK FACTORS; ROC CURVE;

EID: 0034862097     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001721-200109000-00011     Document Type: Article

References (15)

1. Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease
2. Hypercoagulability and ischemic heart disease
3. Fibrinolytic activity, clotting factors, and long-term incidence of ischemic heart disease in the Northwick Park Heart Study
4. Plasminogen activator inhibitor 1 and atherothrombosis
5. Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction
6. Involvement of the hemostatic system in the insulin resistance syndrome. A study of 1500 patients with angina pectoris
7. Plasminogen activator inhibitor in plasma: Risk factor for recurrent myocardial infarction
8. Markers of activated coagulation for early diagnosis of acute myocardial infarction
9. Short activated partial thromboplastin times are related to increased thrombin generation and an increased risk for thromboembolism
10. Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents
11. Utilization and predictive value of laboratory tests in patients referred to rheumatologists by primary care physician
12. The relationships among performance measures in the selection of diagnostic tests
13. Diagnostic strategies in venous thromboembolism
14. Partial thromboplastin time: Prediction of adverse events and poor prognosis by low abnormal values